Advisory Alpha’s Repligen RGEN Stock Holding History

Advisory Alpha’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-147	Closed	-$24K	–	532
2020 Q3	$24K	Buy	+147	New	+$21K	0.01%	304
2020 Q2	–	Sell	-108	Closed	-$12.2K	–	499
2020 Q1	$12.2K	Hold	108	–	–	﹤0.01%	384
2019 Q4	$10.7K	Sell	108 -280	-72%	-$23.5K	﹤0.01%	490
2019 Q3	$29.3K	Buy	+388	New	+$33.9K	0.01%	315
2019 Q2	–	Sell	-100	Closed	-$6.99K	–	529
2019 Q1	$6.99K	Buy	+100	New	+$5.75K	﹤0.01%	449

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Advisory Alpha's RGEN Position: Q4 2020 in Review

Advisory Alpha sold out of Repligen (RGEN) in Q4 2020, closing a stake of 147 shares — an estimated $24K sold.

Advisory Alpha first reported a position in RGEN in Q1 2019 and held it in 5 quarters. The position peaked at $29.3K in Q3 2019. 449 funds tracked by Wall St. Rank hold RGEN as of Q4 2020.

Advisory Alpha reported no remaining Repligen position as of Q4 2020 after selling out during the quarter.
Advisory Alpha sold 147 Repligen shares in Q4 2020, an estimated $24K.
Advisory Alpha first reported a position in Repligen in Q1 2019 and held it in 5 quarters.
Advisory Alpha's Repligen position peaked at $29.3K in Q3 2019.
449 funds tracked by Wall St. Rank held Repligen as of Q4 2020.

Based on Advisory Alpha's 13F filing for Q4 2020, filed 16 Feb 2021.